⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Alkem Laboratories LimitedALKEM

ALKEM₹5,347.5▲ 0.87% today
Nifty Midcap 150

Alkem Laboratories is a leading branded-generics company in India.

Key productsAcute & chronic branded generics (Clavam, Pan-D), US generics.
GeographyIndia and the US.
CompetitorsSun Pharma, Mankind, Cipla.

AI-generated overview — verify before relying on it.

Net institutional flow

+₹103.5 Cr

Institutional buyers

16 in / 1 out

High-impact filings

0 · tilt Neutral

Next corporate action

Interim Dividend - Rs 43 Per Share

ex 2026-02-20

Competitive landscape — the read

vs mapped peers · ALL
1M3M6M1Y2YAll
Institutional money is backing ALKEM hardest (+₹1,013.7 Cr net). ALKEM leads this set on institutional accumulation. Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ALKEMThis+₹1,013.7 Cr13——-26
2CIPLA————+1944
3DRREDDY————+2046
4SUNPHARMA————+1545
5TORNTPHARM——————
6LUPIN——————
7ZYDUSLIFE——1+1——
8AUROPHARMA——————
9MANKIND——————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • • [object Object]
  • • [object Object]
  • • [object Object]
  • • [object Object]

Weaknesses

  • • [object Object]
  • • [object Object]
  • • [object Object]
  • • [object Object]

Opportunities

  • • [object Object]
  • • [object Object]
  • • [object Object]
  • • [object Object]

Threats

  • • [object Object]
  • • [object Object]
  • • [object Object]
  • • [object Object]

AI-generated from our data — verify before relying on it.

Timeline — ALKEM day by day

1M3M6M1Y2YAll
  1. 2026-06-15FilingAlkem Laboratories Limited has informed the Exchange about Schedule of meetInvestor Call
  2. 2026-06-10FilingAlkem Laboratories Limited has informed the Exchange about Schedule of meetInvestor Call
  3. 2026-06-02BulkBUY · ₹469.8 CrICICI PRUDENTIAL MUTUAL FUND
  4. 2026-06-02BulkSELL · ₹643.9 CrJAYANTI SINHA
  5. 2026-06-02BlockBUY · ₹25 CrBNP PARIBAS ARBITRAGE - ODI
  6. 2026-06-02BlockBUY · ₹45 CrDSP MUTUAL FUND
  7. 2026-06-02BlockBUY · ₹25 CrEDELWEISS MUTUAL FUND
  8. 2026-06-02BlockBUY · ₹25 CrGOLDMAN SACHS BANK EUROPE SE
  9. 2026-06-02BlockBUY · ₹265 CrHDFC MUTUAL FUND
  10. 2026-06-02BlockBUY · ₹469.8 CrICICI PRUDENTIAL MUTUAL FUND
  11. 2026-06-02BlockSELL · ₹643.9 CrJAYANTI SINHA
  12. 2026-06-02BlockBUY · ₹25 CrMORGAN STANLEY ASIA SINGAPORE PTE
  13. 2026-06-02BlockBUY · ₹25 CrNIPPON INDIA MUTUAL FUND
  14. 2026-06-02BlockSELL · ₹286 CrSAMPRADA&NANHAMATI SINGH FAMILY TRUST
  15. 2026-06-02BlockBUY · ₹25 CrSOCIETE GENERALE
  16. 2026-06-02NetDay net −₹174 Cr
  17. 2026-06-01NewsAlkem Laboratories to open trading window on June 1, 2026scanx.trade
  18. 2026-05-31NewsEarnings Miss: Alkem Laboratories Limited Missed EPS By 8.9% And Analysts Are Revising Their Forecastssimplywall.st
  19. 2026-05-25NewsAlkem Laboratories schedules meeting with SBI Mutual Fundscanx.trade
  20. 2026-05-12NewsAlkem Laboratories stock (INE540L01014): Indian pharma leader near 52-week highsAD HOC NEWS
  21. 2026-04-24NewsAlkem Labs CEO Dr. Vikas Gupta resigns; stock falls nearly 3%BusinessLine
  22. 2026-02-20ActionInterim Dividend - Rs 43 Per ShareDividend
  23. 2026-02-13NewsAlkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Upsimplywall.st
  24. 2025-08-08ActionDividend - Rs 8 Per ShareDividend
  25. 2025-02-21BulkSELL · ₹300.3 CrSAMPRADA&NANHAMATI SINGH FAMILY TRUST
  26. 2025-02-21BlockSELL · ₹300.3 CrSAMPRADA&NANHAMATI SINGH FAMILY TRUST
  27. 2025-02-21BlockBUY · ₹300.3 CrSBI MUTUAL FUND
  28. 2025-02-21NetDay net −₹300.3 Cr
  29. 2025-02-14ActionInterim Dividend - Rs 37 Per ShareDividend
  30. 2024-11-25BulkSELL · ₹541.2 CrUBS PRINCIPAL CAPITAL ASIA LIMITED
  31. 2024-11-25NetDay net −₹541.2 Cr
  32. 2024-08-22BlockBUY · ₹49.9 CrTATA MUTUAL FUND
  33. 2024-08-22BlockBUY · ₹26.4 CrSOCIETE GENERALE
  34. 2024-08-22BlockSELL · ₹487.2 CrSAMPRADA&NANHAMATI SINGH FAMILY TRUST
  35. 2024-08-22BlockBUY · ₹35 CrRELIANCE NIPPON LIFE INSURANCE COMPANY LIMITED
  36. 2024-08-22BlockBUY · ₹56.2 CrMORGAN STANLEY ASIA SINGAPORE PTE-ODI
  37. 2024-08-22BlockBUY · ₹20.1 CrMORGAN STANLEY ASIA SINGAPORE PTE
  38. 2024-08-22BlockBUY · ₹35 CrKOTAK MAHINDRA MUTUAL FUND
  39. 2024-08-22BlockBUY · ₹10 CrJM FINANCIAL MUTUAL FUND
  40. 2024-08-22BlockBUY · ₹28.7 CrITI MUTUAL FUND
  41. 2024-08-22BlockBUY · ₹112.9 CrICICI PRUDENTIAL LIFE INSURANCE COMPANY LTD
  42. 2024-08-22BlockBUY · ₹20.1 CrGOLDMAN SACHS INVESTMENTS MAURITIUS I LIMITED
  43. 2024-08-22BlockBUY · ₹10 CrCOPTHALL MAURITIUS INVESTMENT LIMITED-NON ODI ACCOUNT
  44. 2024-08-22BlockBUY · ₹20.1 CrCITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LTD
  45. 2024-08-22NetDay net −₹63.1 Cr
  46. 2024-08-09ActionDividend - Rs 5 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

Bulk & block deals

1M3M6M1Y2YAll

30 deals · 2024-08-22 → 2026-06-02

DateCounterpartyTypeSideValue
2026-06-02ICICI PRUDENTIAL MUTUAL FUNDInstitutionBUY₹469.8 Cr
2026-06-02JAYANTI SINHAHNI / otherSELL₹643.9 Cr
2026-06-02BNP PARIBAS ARBITRAGE - ODIHNI / otherBUY₹25 Cr
2026-06-02DSP MUTUAL FUNDInstitutionBUY₹45 Cr
2026-06-02EDELWEISS MUTUAL FUNDInstitutionBUY₹25 Cr
2026-06-02GOLDMAN SACHS BANK EUROPE SEHNI / otherBUY₹25 Cr
2026-06-02HDFC MUTUAL FUNDInstitutionBUY₹265 Cr
2026-06-02ICICI PRUDENTIAL MUTUAL FUNDInstitutionBUY₹469.8 Cr
2026-06-02JAYANTI SINHAHNI / otherSELL₹643.9 Cr
2026-06-02MORGAN STANLEY ASIA SINGAPORE PTEHNI / otherBUY₹25 Cr

30 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

Results & transcripts

Financial results

None yet.

News & chatter on ALKEM

RSS News

6
Alkem Laboratories to open trading window on June 1, 2026

scanx.trade · 1/6/2026

Earnings Miss: Alkem Laboratories Limited Missed EPS By 8.9% And Analysts Are Revising Their Forecasts

▼simplywall.st · 31/5/2026

Alkem Laboratories schedules meeting with SBI Mutual Fund

scanx.trade · 25/5/2026

Alkem Laboratories stock (INE540L01014): Indian pharma leader near 52-week highs

AD HOC NEWS · 12/5/2026

Alkem Labs CEO Dr. Vikas Gupta resigns; stock falls nearly 3%

▼BusinessLine · 24/4/2026

Alkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Up

simplywall.st · 13/2/2026

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.